Skip to main content

Advertisement

Log in

Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

The aims of this study were (1) to ascertain ciclosporin C2 levels currently being achieved in children with steroid-sensitive nephrotic syndrome (SSNS) and renal transplants (RTs), (2) to determine the feasibility of the use of finger-prick samples for the measurement of ciclosporin levels, and (3) to identify any correlation between hypertrichosis or gingival overgrowth (GO) and level of ciclosporin 2 h post-dose (C2). Seventy-two children (39 with SSNS, 33 with RT) participated. Ciclosporin 12 h trough (C12) and C2 levels were measured in venous and finger-prick samples by high-performance liquid chromatography tandem mass spectroscopy. Photographs of the teeth and back were taken for assessment of GO and hypertrichosis. Mean (±SD) C2 levels in the SSNS and RT groups were 512 (±181) μg/l and 471 (±229) μg/l. There was a highly significant relationship between venous and finger-prick ciclosporin levels (r2 = 0.96, P < 0.0001). Fourteen children had severe GO. There was a small, though statistically significant, impact of ciclosporin level on GO (C2 r2 = 0.12, P = 0.003 and C12 r2 = 0.06, P = 0.038) but no correlation with dose (milligrammes per kilogramme per day or milligrammes per square metre per day) or duration. Seventeen children had moderate or severe hypertrichosis, this being more common in children of South Asian ethnicity (P < 0.0001). There was no correlation between ciclosporin exposure or duration and hypertrichosis. Finger-prick blood sampling may serve as a practical alternative to venepuncture in children receiving ciclosporin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Nashan B, Bock A, Bosmans J-L, Budde K, de Fijter H, Jaques B, Johnston A, Luck R, Midtvedt K, Pallardo LM, Ready A, Salame E, Salizzoni M, Suarez F, Thervet E (2005) Use of Neoral C2 monitoring: a European consensus. Transpl Int 18:768–778

    Article  CAS  Google Scholar 

  2. Levy GA (2001) C2 monitoring strategy for optimising ciclosporin immunosuppression from the Neoral formulation. BioDrugs 15:279–290

    Article  CAS  Google Scholar 

  3. Buchler M, Johnston A (2005) Seeking optimal prescription of cyclosporine ME. Ther Drug Monit 27:3–6

    Article  Google Scholar 

  4. Rinaldi S, Sesto A, Barsotti P, Faraggiana T, Sera F, Rizzoni G (2005) Cyclosporine therapy monitored with abbreviated area under the curve in nephrotic syndrome. Pediatr Nephrol 20:25–29

    Article  Google Scholar 

  5. Fujinaga S, Kaneko K, Takada M, Ohtomo Y, Akashi S, Yamashiro Y (2005) Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome. Pediatr Nephrol 20:1359–1360

    Article  Google Scholar 

  6. Nakahata T, Tanaka H, Tsugawa K, Kudo M, Suziki K, Ito E, Waga S (2005) C1-C2 point monitoring of low-dose cyclosporin A given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome. Clin Nephrol 64:258–263

    Article  CAS  Google Scholar 

  7. Nozu K, Iijima K, Sakaeda T, Okumura K, Nakanishi K, Yoshikawa N, Honda M, Ikeda M, Matsuo M (2005) Cyclosporin A absorption profiles in children with nephrotic syndrome. Pediatr Nephrol 7:910–913

    Article  Google Scholar 

  8. Dobbels F, Van Damme-Lombaert R, Vanhaecke J, De Geest S (2005) Growing pains: non-adherence with the immunosuppressive regimen in adolescent transplant recipients. Pediatr Transplant 9:381–390

    Article  Google Scholar 

  9. David-Neto E, Lemos FB, Furusawa EA, Schwartzman BS, Cavalcante JS, Yagyu EM, Romano P, Ianhez LE (2000) Impact of ciclosporin A pharmacokinetics on the presence of side-effects in pediatric renal transplantation. J Am Soc Nephrol 11:343–349

    CAS  PubMed  Google Scholar 

  10. Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G (1983) Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Peridontol 10:237–246

    Article  CAS  Google Scholar 

  11. Thomason JM, Seymour RA, Ellis JS, Kelly PJ, Parry G, Dark J, Idle JR (1995) Iatrogenic gingival overgrowth in cardiac transplantation. J Peridontol 66:742–746

    Article  CAS  Google Scholar 

  12. Ellis JS, Seymour RA, Robertson P, Butler TJ, Thomason JM (2001) Photographic scoring of gingival overgrowth. J Clin Peridontol 28:81–85

    Article  CAS  Google Scholar 

  13. Thomason JM, Seymour RA, Rawlins MD (1992) Incidence and severity of phenytoin–induced gingival overgrowth in epileptic patients in general medical practice. Community Dent Oral Epidemiol 20:288–291

    Article  CAS  Google Scholar 

  14. Thomas DW, Newcombe RG, Osborne G (2000) Risk factors in the development of cyclosporine-induced gingival overgrowth. Transplantation 70:552–556

    Google Scholar 

  15. Thomas DW, Baboolal K, Subramanian N, Newcombe RG (2001) Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Peridontol 28:706–709

    Article  CAS  Google Scholar 

  16. Thomason JM, Seymour RA, Ellis JS (2005) Risk factors for gingival overgrowth in patients medicated with ciclosporin in the absence of calcium channel blockers. J Clin Peridontol 32:273–279

    Article  CAS  Google Scholar 

  17. Webb NJ, Roberts D, Preziosi R, Keevil BG (2005) Finger prick blood samples can be used to accurately measure tacrolimus levels by tandem mass spectrometry. Pediatr Transplant 9:729–733

    Article  CAS  Google Scholar 

  18. Merton G, Jones K, Lee M, Johnston A, Holt DW (2000) Accuracy of cyclosporine measurements made in capillary blood samples obtained by skin puncture. Ther Drug Monit 22:594–598

    Article  CAS  Google Scholar 

  19. Woods K, Douketis JD, Schnurr T, Kinnon K, Powers P, Crowther MA (2004) Patient preferences for capillary vs venous INR determination in an anticoagulation clinic: a randomized controlled trial. Thromb Res 114:161–165

    Article  CAS  Google Scholar 

  20. Keevil BG, Tierney DP, Cooper DP, Morris MR, Machaal A, Yonan N (2002) Simultaneous and rapid analysis of ciclosporin A and creatinine in finger prick blood samples using liquid chromatography tandem mass spectrometry and its application to C2 monitoring. Ther Drug Monit 24:757–767

    Article  CAS  Google Scholar 

  21. Yonan N, Martyszuk R, Machaal A, Baynes A, Keevil BG (2006) Monitoring of cyclosporin levels in transplant recipients using self administered finger prick sampling. Clin Transplant 20:221–225

    Article  Google Scholar 

  22. Ferriman D, Gallwey JD (1961) Clinical measurement of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447

    Article  CAS  Google Scholar 

  23. Hollis S (1996) Analysis of method comparison studies. Ann Clin Biochem 33:1–4

    Article  Google Scholar 

  24. Pape L, Lehnhardt A, Latta K, Ehrich JH, Offner G (2003) Cyclosporin A monitoring by 2-h levels: preliminary target levels in stable pediatric kidney transplant recipients. Clin Transplant 17:546–548

    Article  CAS  Google Scholar 

  25. Pape L, Ehrich JH, Offner G (2004) Advantages of cyclosporine A using 2-h levels in pediatric kidney transplantation. Pediatr Nephrol 19:1035–1038

    Article  Google Scholar 

  26. Trompeter R, Filler G, Webb NJ, Watson AR, Milford DV, Tyden G, Grenda R, Janda J, Hughes D, Ehrich JH, Klare B, Zacchello G, Brekke IB, McGraw M, Perner F, Ghio L, Balzar E, Friman S, Gusmano R, Stolpe J (2002) Randomised multicentre study comparing tacrolimus with cyclosporin in renal transplantation. Pediatr Nephrol 17:141–149

    Article  Google Scholar 

  27. Mahalati K, Belitsky P, Sketris I, West K, Panek R (1999) Neoral monitoring by simplified sparse sampling area under the concentration curve: its relationship to acute rejection and cyclosporine nephrotoxicity after kidney transplantation. Transplantation 68:55–62

    Article  CAS  Google Scholar 

  28. Mahalati K, Belitsky P, West K, Kiberd B, Fraser A, Sketris I, Macdonald AS, McAlister V, Lawen J (2001) Approaching the therapeutic window for cyclosporine in kidney transplantation: a prospective study. J Am Soc Nephrol 12:828–833

    CAS  PubMed  Google Scholar 

  29. Weber LT, Armstrong VW, Shipkova M, Feneberg R, Wiesel M, Mehls O, Zimmerhackl LB, Lellerich M, Tonshoff B, Members of the German Study Group on Pediatric Renal Transplantation (2004) Cyclosporin A absorption in pediatric renal transplant recipients predicts the risk of acute rejection. Ther Drug Monit 26:415–424

    Article  CAS  Google Scholar 

  30. Kyllönen LE, Salmela KT (2006) Early cyclosporine C0 and C2 monitoring in de novo kidney transplant patients: a prospective randomized single-center pilot study. Transplantation 81:1010–1015

    Article  Google Scholar 

Download references

Acknowledgements

This study was funded by an unrestricted educational grant from Novartis Pharmaceuticals UK. The authors would like to thank the nursing staff in the outpatient departments for collecting the blood samples and all of the following paediatric nephrologists who contributed patients to the study: Dr. Jim Beattie, Dr. Mark Bradbury, Dr. Sally Hulton, Dr. Heather Lambert, Dr. Malcolm Lewis, Dr. David Milford, Dr. Nadeem Moghal, Dr. Milos Orjanovic, Dr. Nick Plant, Dr. Ian Ramage, Dr. Judy Taylor, Dr. Mark Taylor and Dr. Judith van der Voort.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nicholas J. A. Webb.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Webb, N.J.A., Coulthard, M.G., Trompeter, R.S. et al. Correlation between finger-prick and venous ciclosporin levels: association with gingival overgrowth and hypertrichosis. Pediatr Nephrol 22, 2111–2118 (2007). https://doi.org/10.1007/s00467-007-0586-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-007-0586-z

Keywords

Navigation